RNTX
Rein Therapeutics Inc
0.825$
+3.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 17.2% | 12.9% | 21.2% | 17.9% | 22.0% | 14.5% | 11.5% | 9.6% | 17.9% | 20.7% | 62.8% | |
| 94.1% | 16.3% | 12.1% | 20.0% | 16.9% | 20.7% | 12.9% | 10.0% | 7.5% | 13.3% | 16.9% | 12.9% | |
| 94.1% | 16.3% | 12.1% | 20.0% | 16.9% | 20.7% | 12.9% | 10.0% | 7.5% | 13.3% | 16.9% | 61.6% | |
| – | 6.0% | 6.4% | 5.8% | 6.1% | 10.2% | 11.0% | 11.0% | 11.8% | 26.2% | 24.1% | 9.6% | |
| – | 74.7% | 79.8% | 72.4% | 76.0% | 67.9% | 73.2% | 73.4% | 78.6% | 55.9% | 51.4% | 20.5% | |
| 12.7% | 93.5% | 54.9% | 48.8% | 51.8% | 12.5% | 91.5% | 94.8% | 14.0% | 30.0% | 55.9% | 84.5% | |
| 12.7% | 4.1% | 4.6% | 4.5% | 5.4% | 9.2% | 10.4% | 13.4% | 10.7% | 25.6% | 51.9% | 14.7% | |
| – | 0.0% | – | – | – | – | – | – | – | – | 18.7% | – | |
| 3.8% | 1.1% | 2.2% | 0.7% | 1.0% | 1.5% | 2.0% | 10.5% | 7.7% | 16.5% | 23.8% | 6.8% | |
| 87.3% | 6.5% | 45.1% | 51.2% | 48.2% | 87.5% | 8.5% | 5.2% | 86.0% | 70.0% | 44.1% | 15.5% | |
| -2,192.9% | -272.2% | -298.0% | -278.4% | -297.9% | -565.0% | -619.3% | -632.8% | -687.6% | -1,661.0% | -1,548.6% | -626.7% | |
| 35.4% | 4.5% | 8.4% | 18.2% | 20.8% | 0.0% | 39.8% | 42.1% | 49.1% | 105.3% | 115.5% | 46.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.